James P. Kelly
2020 - Supernus Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $50,900 |
|---|---|
| Option Awards | $1,641,727 |
| Salary | $102,910 |
| Other | $6,099 |
| Total | $1,801,636 |
Kelly received $1.6M in option awards, accounting for 91% of the total pay in 2020.
Kelly also received $50.9K in non-equity incentive plan, $102.9K in salary and $6.1K in other compensation.
Rankings
In 2020, James P. Kelly's compensation ranked 6,009th out of 13,090 executives tracked by ExecPay. In other words, Kelly earned more than 54.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,009 out of 13,090 | 54th |
Division Manufacturing | 2,477 out of 5,618 | 56th |
Major group Chemicals And Allied Products | 992 out of 2,251 | 56th |
Industry group Drugs | 858 out of 1,951 | 56th |
Industry Pharmaceutical Preparations | 638 out of 1,456 | 56th |
Pay ratio
| James P. Kelly's Pay | $1,801,636 |
|---|---|
| Median Employee's Pay | $148,804 |
| Pay Ratio | 12to 1 |
In 2020, the annual total compensation of James P. Kelly was $1,801,636.
The annual total compensation of the median employee at Supernus Pharmaceuticals was $148,804.
The ratio of James P. Kelly's pay to the pay of median employee was therefore 12 to one.
Kelly's colleagues
We found five more compensation records of executives who worked with James P. Kelly at Supernus Pharmaceuticals in 2020.
2020
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
2020
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
2020
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
2020
Padmanabh Bhatt
Supernus Pharmaceuticals
Chief Scientific Officer
2020
Tami RN
Supernus Pharmaceuticals